Prospective AnalysiS of Self medIcation With phytOtherapy in Nephropatic Patients.

NCT07444515 | Not Yet Recruiting DMC

• 1 other identifier: 2025/RUN/0033
• Study Type: interventional
• Target: 400
• Locations: 1 country
• Sites: 1

Brief Summary

We propose the following hypotheses:

• The use of herbal medicine is common among patients with chronic kidney disease in Réunion island.
• This use could influence the progression of kidney disease in these patients. To assess the primary inclusion criterion, patients will be easily identified by nephrologists through existing follow-up. The questionnaires will be administered after this early identification by the investigators at each center. The primary evaluation criterion is straightforward: it aims to establish an overview of the use of herbal medicine in our patient population. This information is currently unavailable and remains crucial for measuring the extent of the issue. Our secondary criteria will involve more in-depth analysis of this use and an attempt to correlate the use of certain herbs with the rate of progression of kidney disease at one year. We targeted patients with moderate to end-stage chronic kidney disease (KDIGO classification 3 to 5), which are the stages typically included in kidney disease studies. Furthermore, these patients are the most likely to experience a greater annual progression of their kidney disease, and the effect of herbs on this progression could be investigated. Transplant patients were not included because they are more aware of the risks of not using herbal medicine due to their use of immunosuppressants.

Conditions

Chronic Kidney Disease (Stage 3-4); Chronic Kidney Disease (Stages 4 and 5)

Keywords

phytotherapy

Outcome Measures

Primary Outcomes (1)

• Proportion of patients with stage 3 to 5 CKD using traditional herbal medicine at baseline

  baseline

Study Arms (1)

All patient with kidney chronic disease

EXPERIMENTAL

Other: series of questions which can change patient care

Interventions

series of questions which can change patient care OTHER

Series of question are about self medication with plants

All patient with kidney chronic disease

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Individual:
• Adult
• Resident of Réunion Island and planning to remain on the island for the year following enrollment
• Chronic Kidney Disease Stage 3, 4, or 5, not on dialysis
• Under the care of a nephrologist
• Able to complete a questionnaire
• Registered with social security

You may not qualify if:

• Individual:
• Kidney transplant recipient
• Adult under guardianship or legal protection
• Pregnant or breastfeeding women, or women planning a pregnancy during the enrollment period

Sponsors & Collaborators

• Centre Hospitalier Universitaire de la Réunion: lead

Study Sites (1)

Investigator Coordinator

Saint-Denis, 97400, France

Location

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency; Kidney Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Central Study Contacts

Hospital promotion

CONTACT

0262359000; promotion.drci@chu-reunion.fr

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 26, 2026
• First Posted: March 3, 2026
• Study Start: April 2, 2026
• Primary Completion (Estimated): April 2, 2028
• Study Completion (Estimated): July 2, 2028
• Last Updated: March 3, 2026

Record last verified: 2026-02

Locations

FR (1)